105-7100-060
Medtronic Onyx 18 Liquid Embolic System w/Onyx LES, DMSO & Syringes
$2,999.00
kits
Out of stock
Expiration:
In-Date
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
We currently do not have this item in stock, but we can email you as soon as it is available!
Medtronic Monosof clear 18" P-13 cutting
$1.00 packets
Chromic Gut 27" SH taper
$3.15 packets
Medtronic Surgipro blue 36" V-20 taper, double armed
$3.00 packets
Ethibond green 30" C-1 taper
$286.00 box of 36
Medtronic Polysorb undyed 30" V-20 taper
$2.00 packets
Medtronic Polysorb violet 30" GU-46 taper
$1.50 packets
Description
Onyx® LES
Onyx® is a non-adhesive liquid embolic agent used for the pre-surgical embolization of brain Arteriovenous malformations (bAVM).
- Onyx is comprised of EVOH (ethylene vinyl alcohol) copolymer dissolved in DMSO (dimethyl sulfoxide), and suspended micronized tantalum powder to provide contrast for visualization under fluoroscopy.
- The Onyx Liquid Embolic System (LES) consists of a 1.5 ml vial of Onyx, a 1.5 ml vial of DMSO, and three 1 ml Onyx delivery syringes.
- A DMSO compatible delivery micro catheter that is indicated for use in the neuro vasculature (e.g. Marathon™, Rebar® or UltraFlow™ HPC catheters) is used to access the embolization site.
- Onyx is available in two product formulations, Onyx 18 (6% EVOH) and Onyx 34 (8% EVOH).
- Onyx 18 will travel more distally and penetrate deeper into the nidus due to its lower viscosity compared to Onyx 34.
- Final solidification occurs within five minutes for both product formulations.
Additional information
| Size | 1 |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Unit | kits |
- FDA Product Code: MFE
- FDA Product Code Name: Agent, injectable, embolic
- GMDN Term Code: 60939
- GMDN Term Name: Neurovascular embolization plug
- GMDN Term Description: A non-bioabsorbable material (e.g., gel, liquid) intended to be implanted in a neurovascular blood vessel, to obstruct blood flow to treat a brain arteriovenous malformation (bAVM). It may be supplied as a liquid [e.g., ethylene vinyl alcohol (EVOH)], gel or powder intended to solidify or expand in situ to create a barrier to blood flow (embolus); it contains no pharmaceutical agents. It may be supplied with dedicated instruments for implantation.
